Latham & Watkins, Wilson Sonsini, and Fried Frank Advise on Boston Scientific’s $1.16B Silk Road Medical Acquisition
In Short: Boston Scientific Corp., with guidance from Latham & Watkins, is set to acquire Silk Road Medical Inc. for roughly $1.16 billion. This deal positions Boston Scientific to enhance its capabilities in stroke prevention and carotid artery disease treatment.
This post is for paying subscribers only
SubscribeAlready have an account? Log in
